Aveanna Healthcare Holdings DEF 14A Filing
Ticker: AVAH · Form: DEF 14A · Filed: Mar 25, 2025 · CIK: 1832332
| Field | Detail |
|---|---|
| Company | Aveanna Healthcare Holdings, Inc. (AVAH) |
| Form Type | DEF 14A |
| Filed Date | Mar 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
TL;DR
Aveanna Healthcare's DEF 14A is out, showing exec pay details for 2023. Focus on equity awards and board comp.
AI Summary
Aveanna Healthcare Holdings, Inc. filed a DEF 14A on March 25, 2025, detailing executive compensation and related matters for the fiscal year ending December 31, 2023. The filing includes information on equity awards, changes in their value, and vesting conditions for named executive officers, as well as details on the company's board of directors and their compensation.
Why It Matters
This filing provides transparency into how Aveanna Healthcare compensates its top executives and directors, which can influence investor perception of corporate governance and financial health.
Risk Assessment
Risk Level: medium — DEF 14A filings, while routine, can reveal details about executive compensation and corporate governance that may impact investor confidence and stock price.
Key Numbers
- 2023-12-31 — Fiscal Year End (Reporting period for financial data presented in the filing.)
- 20250325 — Filing Date (Date the DEF 14A filing was submitted to the SEC.)
Key Players & Entities
- Aveanna Healthcare Holdings, Inc. (company) — Filer
- 0001832332 (company) — Central Index Key
- 8082 (company) — Standard Industrial Classification Code
- 844717209 (company) — EIN
- DE (company) — State of Incorporation
- 0101 (company) — Fiscal Year End
- 001-40362 (company) — SEC File Number
- 25768310 (company) — Film Number
- 400 INTERSTATE NORTH PARKWAY STE 1700 ATLANTA GA 30339 (company) — Business Address
- 770-441-1580 (company) — Business Phone
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by a company to solicit proxies from shareholders for an upcoming annual or special meeting. It provides detailed information about matters to be voted on, including executive compensation, director elections, and other corporate governance issues.
What period does the financial data in this filing primarily cover?
The filing references fiscal year end dates of 2023-12-31, 2024-12-28, and 2022-12-31, indicating that the financial data and compensation details presented relate to these periods, with a focus on 2023.
Who are the key individuals or groups whose compensation is detailed in this filing?
This filing details executive compensation and compensation for members of the board of directors. Specific named executive officers are typically listed within the compensation tables and discussions.
What types of equity awards are discussed in the filing?
The filing mentions various equity awards, including changes in their fair value, vesting conditions, and awards granted in prior years that vested during the covered year. Specific types like 'EqtyAwrdsAdjsMember' and 'NonPeoNeoMember' are referenced.
What is the company's primary business as indicated by its SIC code?
The company's Standard Industrial Classification (SIC) code is 8082, which corresponds to SERVICES-HOME HEALTH CARE SERVICES.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 25, 2025 regarding Aveanna Healthcare Holdings, Inc. (AVAH).